AF

Carl Zeiss Meditec AGDUS Carl Zeiss Stock Report

Last reporting period 31 Mar, 2023

Updated 13 Nov, 2024

Last price

Market cap $B

6.063

Middle

Exchange

XDUS - Boerse Duesseldorf

AFX.DU Stock Analysis

AF

Uncovered

Carl Zeiss Meditec AG is uncovered by Eyestock quantitative analysis.

Market cap $B

6.063

Dividend yield

1.90 %

Shares outstanding

89.441 B

Carl Zeiss Meditec AG engages in the development, manufacture and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 4,224 full-time employees. The company went IPO on 2000-03-20. The company offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The firm has various production sites in Europe, the United States and Asia.

View Section: Eyestock Rating